Company: NOTV
Filing Date: 2025-08-29
Form Type: S-3
Source: 0001628280-25-041413
Chunk: 55

Company: Inotiv, Inc.
Filing Date: 2025-08-29
Form: S-3
Chunk 55
---
, the trading price of our common shares could decline and you could lose all or part of your investment. These risks and uncertainties are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. See “ Cautionary Note Regarding Forward-Looking Statements ” elsewhere in this prospectus supplement.

#### Risks Related to This Offering
We may allocate any net proceeds from this offering in ways that you or other stockholders may not approve.

We currently intend to use any net proceeds of this offering for working capital and other general corporate purposes. This expected use of any net proceeds from this offering represents our intentions based upon our current plans and business conditions. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including, but not limited to, general market conditions, required capital investments, regulatory requirements and customer demands. Because the number and variability of factors that will determine our use of any proceeds from this offering, their ultimate use may vary substantially from their currently intended use. As a result, our management will retain broad discretion over the allocation of any net proceeds from this offering and could spend such proceeds in ways that do not necessarily improve our operating results or enhance the value of our common shares. See “ Use of Proceeds .”

You may experience immediate and substantial dilution in the book value per share of the common shares you purchase.

Because the prices per share at which common shares are sold in this offering may be substantially higher than the book value per share of our common shares, you may suffer immediate and substantial dilution in the net tangible book value of the common shares you purchase in this offering. The shares sold in this offering, if any, will be sold from time to time at various prices. If we sell shares in this offering at a price that is higher than the book value per share of our common shares, investors in this offering will experience dilution. See “ Dilution .”

We plan to sell shares of our common shares in “at-the-market offerings,” and investors who buy common shares at different times will likely pay different prices.

Investors who purchase common shares in the offering described in this prospectus supplement at different times will likely pay different prices and may experience different outcomes in their investment results. We will have discretion, subject to the effect of market conditions, to vary the timing, prices, and numbers of shares sold in this offering. Investors may experience a decline in the value of their common shares.

It is not